Tech Center 1600 • Art Units: 1613 1621 1645 1651 1657
This examiner grants 40% of resolved cases
Examiner Crum presents a challenging path in Art Unit 1613, with an allowance rate of 40.4% across 94 resolved cases. This suggests a rigorous examination process in Tech Center 1600. The median days to allowance of 1322 further highlights the difficulty, showing a very long timeline. These metrics, based on 94 resolved cases, indicate that securing a patent requires both persistence and a high level of technical justification.
However, the interview lift of 65.0% is exceptionally high. This suggests that for the 94 resolved cases, an interview was almost always necessary to achieve an allowance. Given the low 40.4% baseline allowance rate and the long 1322-day median pendency, an interview is an essential and highly effective tool for any applicant assigned to this examiner. The 65.0% lift is a clear signal that the examiner is extremely responsive to verbal arguments and collaborative problem-solving. Utilizing this tool is the most effective way to navigate the 1322-day timeline and improve the probability of success in this rigorous art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18686249 | AUTONOMOUS ORGANISMS FOR SYNTHESIS OF PERMANENTLY PHOSPHORYLATED PROTEINS | Non-Final OA | Oregon State University |
| 17652464 | PROBIOTIC THERAPIES FOR SOCIAL DEFICIT AND STRESS RESPONSE | Final Rejection | California Institute of Technology |
| 19305204 | IMMUNOMODULATORY COMPOSITIONS AND METHODS | Final Rejection | Innate Biologics LLC |
| 17514472 | IMMUNOMODULATORY COMPOSITIONS AND METHODS | Non-Final OA | Innate Biologics LLC |
| 18722396 | METHOD OF BACTERIAL IDENTIFICATION AND TESTING OF BACTERIUM RESISTANT TO ONE OR MORE ANTIBIOTICS | Final Rejection | Nanyang Technological University |
| 17410360 | PROBIOTICS AND PROBIOTIC COMPOSITIONS HAVING MODIFIED CARBOHYDRATE METABOLISM | Non-Final OA | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 17631943 | COMPOSITION COMPRISING A LIPASE | Non-Final OA | Novozymes A/S |
| 17618927 | Alpha-Amylase Variants | Final Rejection | Novozymes A/S |
| 17601019 | Liquid Dishwashing Detergent Compositions | Final Rejection | Novozymes A/S |
| 17971072 | MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY | Final Rejection | The Board of Regents of the University of Oklahoma |
| 17628094 | IMPROVED METHOD FOR PRODUCING ISOMALTOOLIGOSACCHARIDES | Final Rejection | DANISCO US INC |
| 18682241 | ANALYTICAL METHODS FOR BACTERIAL IDENTIFICATION AND ANTIBIOTIC SUSCEPTIBILITY TESTING IN BIOLOGICAL SAMPLES | Final Rejection | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA |
| 17606145 | COMPOSITION CONTAINING GLUCORAPHANIN AND USE THEREOF | Final Rejection | SHENZHEN FUSHAN BIOTECH CO., LTD. |
| 17386266 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | Final Rejection | MICROBIAL RESOURCE MANAGEMENT HEALTH NV (MRM HEALTH) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy